Molecule

Lenvatinib

17 brands of Lenvatinib in stock, compared side by side.

We stock 17 brands of Lenvatinib from 9 manufacturers (capsule; 4 mg and 10 Mg). The lowest per-unit price is USD $ 1.30, for Glenvas 4 Mg Capsule. Every brand listed is prescription-only: you can upload your prescription at checkout or from your account.

Brands of this molecule, with strength, pack size and price
Brand Manufacturer Strength Pack Price Per unit Availability
Glenvas 4 Mg Capsule Glenmark Pharmaceuticals 4 mg 10 Capsules USD $ 13.00 USD $ 1.30 In stock
Lenta 4 Mg Capsule Dr. Reddy's 4 mg 10 Capsules USD $ 15.00 USD $ 1.50 In stock
Ca Lenvanib 4 Mg Capsule Amps Biotech 4 mg 10 Capsules USD $ 19.00 USD $ 1.90 In stock
Lentris 4 Mg Capsule Mylan Pharmaceuticals 4 mg 10 Capsules USD $ 22.00 USD $ 2.20 In stock
Lenvenib 4 Mg Capsule Sun Pharmaceutical 4 mg 7 Capsules USD $ 45.00 USD $ 6.43 In stock
Lenvatol 4 Mg Capsule Cipla Ltd. 4 mg 10 Capsules USD $ 49.00 USD $ 4.90 In stock
Lenvaxen 4 Mg Capsules Everest Pharmaceuticals 4 mg 30 Capsules USD $ 140.00 USD $ 4.67 In stock
Lenvat 4 Mg Capsules Natco Pharma 4 mg 30 Capsules USD $ 170.00 USD $ 5.67 In stock
Lenvima 4 Mg Capsules Eisai Pharmaceuticals 4 mg 40 Capsules USD $ 880.00 USD $ 22.00 In stock
Lenta 10 Mg Capsule Dr. Reddy's 10 Mg 10 Capsules USD $ 35.00 USD $ 3.50 In stock
Ca Lenvanib 10 Mg Capsule Amps Biotech 10 Mg 10 Capsules USD $ 44.00 USD $ 4.40 In stock
Lentris 10 Mg Capsule Mylan Pharmaceuticals 10 Mg 10 Capsules USD $ 45.00 USD $ 4.50 In stock
Lenvenib 10 Mg Capsule Sun Pharmaceutical 10 Mg 7 Capsules USD $ 45.00 USD $ 6.43 In stock
Lenvatol 10 Mg Capsule Cipla Ltd. 10 Mg 10 Capsules USD $ 49.00 USD $ 4.90 In stock
Lenvaxen 10 Mg Capsules Everest Pharmaceuticals 10 Mg 30 Capsules USD $ 140.00 USD $ 4.67 In stock
Lenvat 10 Mg Capsules Natco Pharma 10 Mg 30 Capsules USD $ 225.00 USD $ 7.50 In stock
Lenvima 10 Mg Capsules Eisai Pharmaceuticals 10 Mg 40 Capsules USD $ 1,699.00 USD $ 42.48 In stock

About Lenvatinib

Lenvatinib is an oral multi-kinase inhibitor used to treat differentiated thyroid cancer, advanced renal cell carcinoma (in combination with pembrolizumab or everolimus), hepatocellular carcinoma, and advanced endometrial carcinoma. It works by blocking VEGFR1-3, FGFR1-4, RET, KIT, and PDGFR-alpha, inhibiting both tumour growth and the blood vessel formation that supports it.

Marketed as Lenvima, lenvatinib is taken as a once-daily oral capsule. In hepatocellular carcinoma, it demonstrated non-inferiority to sorafenib as a first-line treatment. The combination of lenvatinib with pembrolizumab has become a standard of care in several tumour types. Indian manufacturers produce lenvatinib in 4 mg and 10 mg capsule strengths.

At a glance

Brands in stock
17
Strengths
4 mg / 10 Mg
Manufacturers
9
From
USD $ 13.00